Submitted by Anonymous (not verified) on 19 October 2026 - 16:25
Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Status: Authorised
Source: